Momenta Phama (MNTA) Says '17 Approval Possible for its Copaxone Generic - Bloomberg, Citing Email
Momenta Phama (NASDAQ: MNTA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
